Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, today announced the successful completion of Series A4 financing. Sequoia Capital China led this round of investment, and was joined by Green Pine Capital Partners and Primavera Venture Partners. IDG Capital, the original founding investor for Analytical Biosciences, also participated in this financing round. Analytical […]
CAPZA, an independent management company and leading player in private investments in European SMEs – invests in Xenocs, a French deep tech company, through its new Growth Tech strategy. Founded in 2000, Xenocs is a spin-off from the Institut Laue-Langevin (ILL). The company operates on the nanoscale material characterization market through the development and production […]
Marlborough, MA: Scitara Corporation, a global provider of laboratory-specific, cloud-based software solutions for the biopharmaceutical and industrial markets, today announced the closing of $5 million in a Series A round. The investment was led by Northpond Ventures, with participation from existing investor Flybridge Capital. Scitara will use the investment to fully build out its Digital Lab Exchange™ (DLX) platform, partner […]
Industry Veteran Brian Dutko Named New CEO to Support a Transformational Growth Strategy, Including Pursuit of Strategic Acquisitions RYE, N.Y. and BILLERICA, Mass. — SFW Capital Partners, LP (“SFW”) today announced that it has completed a majority recapitalization of Pion Inc. (“Pion”), a leading provider of analytical instrumentation for formulation development and quality control in the life sciences industry. Mike and […]
Funding will be used to advance the development of AI-based cell analysis and sorting platforms in cell therapy and diagnostics Tokyo, Japan — ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today the completion of a $26 million (JPY 2.85 billion) Series B financing, led […]
M12 – Microsoft’s Venture Fund – leads Artificial’s Series A to accelerate product development, grow its world-class team, and establish life science partnerships to advance breakthroughs Palo Alto, Calif – Business Wire – Artificial, a software company providing a first-of-its-kind lab automation platform, announced today the close of their $21.5M Series A investment round. The […]
Funds played a key role in positioning LUMICKS for future success Amsterdam, the Netherlands — LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, announces that it has made the decision to return the COVID-related relief funding it received in both the Netherlands […]
Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp’s Chief Operating Officer TOKYO — Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries, today announced it has raised a $50 million Series D financing, led […]
Separation Will Create Focused, High-Growth Life Sciences and Automation Companies Tax-Efficient Separation Expected to be Completed by End of Calendar Year 2021 CHELMSFORD, Mass. — Brooks Automation, Inc. (“Brooks”) (Nasdaq: BRKS) today announced its intention to separate its business into two independent, and publicly-traded companies. The transaction is intended to be structured as a pro-rata distribution of […]
TwinStrand’s transformational improvements in DNA sequencing accuracy deliver 10,000x greater sensitivity, making it a crucial tool for genomic research and medicine Financing was led by Section 32 partner Michael Pellini, MD who has also joined the company’s Board of Directors TwinStrand Biosciences, the pioneer and developer of Duplex Sequencing, an ultra-high accuracy technology for revealing […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
